Literature DB >> 21893307

Risk factors for opioid-induced excessive respiratory depression.

Carla R Jungquist1, Suzanne Karan, Michael L Perlis.   

Abstract

Opioid use has increased significantly over the past ten years and so has the incidence of reportable adverse events, such as respiratory depression and/or arrest. It is important for nurses to understand and know how to assess patients for risk factors for respiratory depression secondary to opioid therapy. This paper presents the pharmacodynamics of opioids, the risk factors for excessive respiratory depression, recommendations for identifying patients at high risk, and interventions to prevent adverse effects. After reading this paper, nurses will have the knowledge to provide safe administration of opioid medications for the management of acute pain.
Copyright © 2011 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21893307     DOI: 10.1016/j.pmn.2010.02.001

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  5 in total

1.  Fentanyl effects on breath generation in C57BL/6J and A/J mouse strains.

Authors:  Linnea Fechtner; Mazen El Ali; Abdus Sattar; Michael Moore; Kingman P Strohl
Journal:  Respir Physiol Neurobiol       Date:  2015-04-30       Impact factor: 1.931

Review 2.  Caring for patients with opioid use disorder in the hospital.

Authors:  Joseph H Donroe; Stephen R Holt; Jeanette M Tetrault
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

3.  Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients.

Authors:  Barbara Zedler; Lin Xie; Li Wang; Andrew Joyce; Catherine Vick; Janet Brigham; Furaha Kariburyo; Onur Baser; Lenn Murrelle
Journal:  Pain Med       Date:  2015-06-05       Impact factor: 3.750

4.  Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations.

Authors:  Pramit A Nadpara; Andrew R Joyce; E Lenn Murrelle; Nathan W Carroll; Norman V Carroll; Marie Barnard; Barbara K Zedler
Journal:  Pain Med       Date:  2018-01-01       Impact factor: 3.750

5.  The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Authors:  Wei Dai; Xiang Gao; Dian Xiao; Yu-Lei Li; Xin-Bo Zhou; Zheng Yong; Rui-Bin Su
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.